Axcess News – Lifestyle
Author:
Century Therapeutics, Inc.
Century Therapeutics Selected for Oral Presentation of CNTY‑813 Preclinical Data at the American Diabetes Association 86th Scientific Sessions
April 30, 2026
Century Therapeutics Reports Full Year 2025 Financial Results and Business Updates
March 12, 2026
Century Therapeutics to Participate in Upcoming Investor Conferences in March
March 5, 2026